20-44624205-G-C
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM3PVS1PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The c.603C>G (p.Tyr201Ter) (NM_000022.4) variant in ADA is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 6/12 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1_Met). The highest population minor allele frequency in gnomAD v4 is 0.00002992 (1/33422 alleles) in African/African American population, which is lower than the ClinGen SCID VCEP threshold (<0.0001742) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). There are no publications for this variant in the literature. Patient # 46 was found to be heterozygous for c.603C>G (p.Tyr201*) and c.632G>A (p.Arg211His) which is classified as pathogenic for SCID by the ClinGen SCID VCEP (1 pt.) (PMID:26255240, PM3).In summary, this variant meets the criteria to be classified as a Pathogenic variant for autosomal recessive severe combined immunodeficiency due to ADA deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: PM2_supporting,PM3,PVS1 (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA409120740/MONDO:0007064/114
Frequency
Consequence
NM_000022.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ADA | NM_000022.4 | c.603C>G | p.Tyr201* | stop_gained | Exon 6 of 12 | ENST00000372874.9 | NP_000013.2 | |
| ADA | NM_001322051.2 | c.603C>G | p.Tyr201* | stop_gained | Exon 6 of 11 | NP_001308980.1 | ||
| ADA | NM_001322050.2 | c.198C>G | p.Tyr66* | stop_gained | Exon 5 of 11 | NP_001308979.1 | ||
| ADA | NR_136160.2 | n.695C>G | non_coding_transcript_exon_variant | Exon 6 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ADA | ENST00000372874.9 | c.603C>G | p.Tyr201* | stop_gained | Exon 6 of 12 | 1 | NM_000022.4 | ENSP00000361965.4 | ||
| ADA | ENST00000696038.1 | n.*349C>G | non_coding_transcript_exon_variant | Exon 6 of 9 | ENSP00000512344.1 | |||||
| ADA | ENST00000696038.1 | n.*349C>G | 3_prime_UTR_variant | Exon 6 of 9 | ENSP00000512344.1 | |||||
| ADA | ENST00000695995.1 | c.217-1127C>G | intron_variant | Intron 3 of 8 | ENSP00000512318.1 | |||||
| ADA | ENST00000695991.1 | c.217-1275C>G | intron_variant | Intron 3 of 7 | ENSP00000512314.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1458990Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 725600 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency Pathogenic:3
The c.603C>G (p.Tyr201Ter) (NM_000022.4) variant in ADA is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 6/12 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1_Met). The highest population minor allele frequency in gnomAD v4 is 0.00002992 (1/33422 alleles) in African/African American population, which is lower than the ClinGen SCID VCEP threshold (<0.0001742) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). There are no publications for this variant in the literature. Patient # 46 was found to be heterozygous for c.603C>G (p.Tyr201*) and c.632G>A (p.Arg211His) which is classified as pathogenic for SCID by the ClinGen SCID VCEP (1 pt.) (PMID: 26255240, PM3). In summary, this variant meets the criteria to be classified as a Pathogenic variant for autosomal recessive severe combined immunodeficiency due to ADA deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: PM2_supporting,PM3,PVS1 (VCEP specifications version 1). -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
This sequence change creates a premature translational stop signal (p.Tyr201*) in the ADA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADA are known to be pathogenic (PMID: 26255240, 26376800). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal recessive severe combined immunodeficiency due to adenosine deaminase deficiency (PMID: 26255240). ClinVar contains an entry for this variant (Variation ID: 555182). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at